A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Pfizer Inc stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 677,743 shares of PFE stock, worth $16.9 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
677,743
Previous 580,665 16.72%
Holding current value
$16.9 Million
Previous $16.2 Million 20.72%
% of portfolio
0.22%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $2.69 Million - $3.05 Million
97,078 Added 16.72%
677,743 $19.6 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $1.2 Million - $1.4 Million
47,414 Added 8.89%
580,665 $16.2 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $9.84 Million - $11.3 Million
380,046 Added 248.06%
533,251 $14.8 Million
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $19,093 - $22,318
-595 Reduced 0.39%
153,205 $5.08 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $137,833 - $159,470
-3,816 Reduced 2.42%
153,800 $5.64 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $281,362 - $366,293
-7,143 Reduced 4.34%
157,616 $6.43 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $587,422 - $766,815
-14,070 Reduced 7.87%
164,759 $8.45 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $951,604 - $1.16 Million
-21,746 Reduced 10.84%
178,829 $7.83 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $366,516 - $434,574
7,877 Added 4.09%
200,575 $10.5 Million
Q1 2022

May 18, 2022

SELL
$45.75 - $56.69 $32,025 - $39,683
-700 Reduced 0.36%
192,698 $9.98 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $101,976 - $126,362
-2,229 Reduced 1.14%
193,398 $10 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $396,300 - $587,448
-9,591 Reduced 4.67%
195,627 $11.6 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $240,759 - $309,276
-6,134 Reduced 2.9%
205,218 $8.83 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $696,546 - $789,069
19,397 Added 10.1%
211,352 $8.28 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $201,710 - $227,488
-6,023 Reduced 3.04%
191,955 $6.96 Million
Q4 2020

Feb 05, 2021

SELL
$33.47 - $42.56 $630,206 - $801,362
-18,829 Reduced 8.68%
197,978 $7.29 Million
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $604,520 - $709,240
-19,040 Reduced 8.07%
216,807 $7.96 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $2.03 Million - $2.46 Million
-67,337 Reduced 22.21%
235,847 $7.71 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $1.14 Million - $1.62 Million
42,073 Added 16.11%
303,184 $9.9 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $767,463 - $870,973
-23,313 Reduced 8.2%
261,111 $10.2 Million
Q3 2019

Nov 01, 2019

SELL
$32.49 - $42.13 $273,825 - $355,071
-8,428 Reduced 2.88%
284,424 $10.2 Million
Q2 2019

Aug 02, 2019

SELL
$36.98 - $41.52 $363,883 - $408,556
-9,840 Reduced 3.25%
292,852 $12.7 Million
Q1 2019

May 02, 2019

SELL
$37.5 - $41.2 $256,462 - $281,766
-6,839 Reduced 2.21%
302,692 $12.9 Million
Q4 2018

Jan 30, 2019

SELL
$38.47 - $43.86 $433,941 - $494,740
-11,280 Reduced 3.52%
309,531 $13.5 Million
Q3 2018

Nov 02, 2018

SELL
$34.47 - $41.81 $743,483 - $901,799
-21,569 Reduced 6.3%
320,811 $14.1 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $1.49 Million - $1.59 Million
-45,121 Reduced 11.64%
342,380 $12.4 Million
Q1 2018

May 09, 2018

BUY
$31.91 - $37.02 $46,907 - $54,419
1,470 Added 0.38%
387,501 $13.8 Million
Q4 2017

Feb 02, 2018

SELL
$33.26 - $35.29 $3.03 Million - $3.21 Million
-91,095 Reduced 19.09%
386,031 $14 Million
Q3 2017

Nov 01, 2017

BUY
$31.0 - $34.15 $14.8 Million - $16.3 Million
477,126
477,126 $17 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.